Kar-Ming Fung to Brain Neoplasms
This is a "connection" page, showing publications Kar-Ming Fung has written about Brain Neoplasms.
Connection Strength
2.962
-
Primary intracranial Ewing's sarcoma with unusual features. Int J Clin Exp Pathol. 2015; 8(1):260-74.
Score: 0.381
-
Differential expression of type 2 3a/type 5 17ß-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system. Int J Clin Exp Pathol. 2010 Mar 25; 3(8):743-54.
Score: 0.273
-
Rhabdoid glioblastoma in an adult. Pathology. 2004 Dec; 36(6):585-7.
Score: 0.189
-
Expression of alpha-, beta-, and gamma-synuclein in glial tumors and medulloblastomas. Acta Neuropathol. 2003 Aug; 106(2):167-75.
Score: 0.170
-
A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007. J Cell Mol Med. 2022 01; 26(2):570-582.
Score: 0.154
-
H3K27M-mutant diffuse midline gliomas should be further molecularly stratified: an integrated analysis of 669 patients. J Neurooncol. 2021 Dec; 155(3):225-234.
Score: 0.153
-
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis. BMC Cancer. 2020 Sep 21; 20(1):897.
Score: 0.141
-
Metastatic Renal Cell Carcinoma to the Brain: A Contemporary Clinicopathologic Analysis With Comparison of Immunohistochemical Profiles to Selected Primary Brain Tumors With Clear Cell Features. Appl Immunohistochem Mol Morphol. 2020 May/Jun; 28(5):395-402.
Score: 0.138
-
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. J Cell Mol Med. 2020 01; 24(2):1738-1749.
Score: 0.134
-
Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features. Brain Pathol. 2020 05; 30(3):479-494.
Score: 0.133
-
Co-occurrence of astrocytoma and astroblastoma: Case report and literature review. Neuropathology. 2018 Oct; 38(5):516-520.
Score: 0.121
-
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups-A meta-analysis of aggregate data. Crit Rev Oncol Hematol. 2017 Dec; 120:1-9.
Score: 0.115
-
BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis. Mol Neurobiol. 2018 May; 55(5):3718-3724.
Score: 0.112
-
ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models. Neuro Oncol. 2017 02 01; 19(2):175-185.
Score: 0.110
-
Primary Intracranial Sarcoma Presenting as Chronic Subdural Fluid Collections in a Child. World Neurosurg. 2016 Feb; 86:514.e13-8.
Score: 0.100
-
Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts. PLoS One. 2015; 10(8):e0134276.
Score: 0.099
-
OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model. J Magn Reson Imaging. 2015 Dec; 42(6):1582-91.
Score: 0.097
-
Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain. Int J Clin Exp Pathol. 2014; 7(12):8947-51.
Score: 0.095
-
The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features. J Neurooncol. 2013 Dec; 115(3):477-86.
Score: 0.087
-
Pyrosequencing of IDH1 and IDH2 mutations in brain tumors and non-neoplastic conditions. Diagn Mol Pathol. 2012 Dec; 21(4):214-20.
Score: 0.082
-
Glioblastoma with PNET-like components has a higher frequency of isocitrate dehydrogenase 1 (IDH1) mutation and likely a better prognosis than primary glioblastoma. Int J Clin Exp Pathol. 2011; 4(7):651-60.
Score: 0.076